Evidence map›Paper›PMID 35741310›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Different Lung Parenchyma Quantification Using Dissimilar Segmentation Software: A Multi-Center Study for COVID-19 Patients.

Camilla Risoli, Marco Nicolò, Davide Colombi, Marco Moia, Fausto Rapacioli, Pietro Anselmi, Emanuele Michieletti, Roberta Ambrosini, Marco Di Terlizzi, Luigi Grazioli and 9 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 1 country.

Camilla RisoliDepartment of Radiological Function, "Guglielmo da Saliceto" Hospital, Via Taverna 49, 29121 Piacenza, Italy.ORCID 0000-0003-0117-7011
Marco NicolòDepartment of Diagnostic Imaging, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy.
Davide ColombiDepartment of Radiological Function, "Guglielmo da Saliceto" Hospital, Via Taverna 49, 29121 Piacenza, Italy.
Marco MoiaDepartment of Radiological Function, "Guglielmo da Saliceto" Hospital, Via Taverna 49, 29121 Piacenza, Italy.
Fausto RapacioliDepartment of Radiological Function, "Guglielmo da Saliceto" Hospital, Via Taverna 49, 29121 Piacenza, Italy.
Pietro AnselmiDepartment of Radiological Function, "Guglielmo da Saliceto" Hospital, Via Taverna 49, 29121 Piacenza, Italy.
Emanuele MichielettiDepartment of Radiological Function, "Guglielmo da Saliceto" Hospital, Via Taverna 49, 29121 Piacenza, Italy.
Roberta AmbrosiniDepartment of Diagnostic Imaging, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy.ORCID 0000-0002-4082-2303
Marco Di TerlizziDepartment of Diagnostic Imaging, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy.
Luigi GrazioliDepartment of Diagnostic Imaging, Spedali Civili di Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy.
Cristian ColmoDepartment of Radiology, Diagnostic Institute Antoniano Affidea, Via Cavazzana, 39/4, 35123 Padova, Italy.
Angelo Di NaroDepartment of Oncology and Hematology, Papa Giovanni XXIII Hospital, Piazza OMS, 1, 24127 Bergamo, Italy.ORCID 0000-0001-5903-9231
Matteo Pio NataleDepartment of Respiratory Disease, University of Foggia, Via Antonio Gramsci, 89, 71122 Foggia, Italy.
Alessandro TombolesiDepartment of Radiology, University Hospital of Città della Salute e della Scienza di, 10127 Torino, Italy.
Altin AdramanDepartment of Radiology, Santa Chiara Hospital, Largo Medaglie d'oro, 9, 38122 Trento, Italy.ORCID 0000-0002-8208-7984
Domenico TuttolomondoDepartment of Cardiology, Parma University Hospital, Via Gramsci 14, 43125 Parma, Italy.ORCID 0000-0002-1291-0306
Cosimo CostantinoDepartment of Medicine and Surgery, University of Parma, 43126 Parma, Italy.ORCID 0000-0003-0563-5235
Elisa VettiDepartment of Health Professions, University of Parma, Maggiore Hospital, Via Gramsci 14, 43125 Parma, Italy.
Chiara MartiniDepartment of Medicine and Surgery, Section of Radiology, University of Parma, Maggiore Hospital, Via Gramsci 14, 43125 Parma, Italy.ORCID 0000-0002-0877-4954
Guglielmo da Saliceto Hospital · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITUniversity of Parma · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITOspedale Papa Giovanni XXIII · ITOspedale Santa Chiara · ITPontifical University Antonianum · ITUniversity of Foggia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundChest Computed Tomography (CT) imaging has played a central role in the diagnosis of interstitial pneumonia in patients affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and can be used to obtain the extent of lung involvement in COVID-19 pneumonia patients either qualitatively, via visual inspection, or quantitatively, via AI-based software. This study aims to compare the qualitative/quantitative pathological lung extension data on COVID-19 patients. Secondly, the quantitative data obtained were compared to verify their concordance since they were derived from three different lung segmentation software.

methodsThis double-center study includes a total of 120 COVID-19 patients (60 from each center) with positive reverse-transcription polymerase chain reaction (RT-PCR) who underwent a chest CT scan from November 2020 to February 2021. CT scans were analyzed retrospectively and independently in each center. Specifically, CT images were examined manually by two different and experienced radiologists for each center, providing the qualitative extent score of lung involvement, whereas the quantitative analysis was performed by one trained radiographer for each center using three different software:

resultsThe agreement between radiologists for visual estimation of pneumonia at CT can be defined as good (ICC 0.79, 95% CI 0.73-0.84). The statistical tests show that 3DSlicer overestimates the measures assessed; however, ICC index returns a value of 0.92 (CI 0.90-0.94), indicating excellent reliability within the three software employed. ICC was also performed between each single software and the median of the visual score provided by the radiologists. This statistical analysis underlines that the best agreement is between 3D Slicer "LungCTAnalyzer" and the median of the visual score (0.75 with a CI 0.67-82 and with a median value of 22% of disease extension for the software and 25% for the visual values).

conclusionsThis study provides for the first time a direct comparison between the actual gold standard, which is represented by the qualitative information described by radiologists, and novel quantitative AI-based techniques, here represented by three different commonly used lung segmentation software, underlying the importance of these specific values that in the future could be implemented as consistent prognostic and clinical course parameters.

Indexed as

chest CTCOVID-19 pneumonialung segmentationpost-processing toolssemi-automatic segmentation software

Identifiers

PMID35741310
PMCPMC9222070
OpenAlexW4283214070

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.